ITGAM and glioma: Comparably, another study in the same GEM mouse of glioma demonstrated that MDSCs constituted about 8% of the total tumor cell mass and mostly consisted of the CD11b+/Gr-1low monocytic subset rather than the CD11b+/Gr-1high granulocytic sub-set at the tumor site [17].